A new report from Biocompare, Inc. finds Invitrogen on top as the preferred RNAi supplier.
SOUTH SAN FRANCISCO, Calif., Aug. 8 /PRNewswire/ -- A new report from Biocompare, Inc., RNAi Report: A Revolutionary Technology, based on a survey of over 600 researchers, announces that respondents identify Invitrogen as their favorite company from which to purchase supplies and reagents for RNA interference (RNAi) research. This shift in customer loyalty signals a major change from one year ago, where Dharmacon, Qiagen, and Ambion dominated the RNAi market. Indeed, these suppliers often placed near the top in this most recent survey, but were unable to catch Invitrogen as the overall favorite.
The survey explores what researchers consider to be important attributes for an RNAi company. The outright winner was the ability to find helpful technical support, followed by knowledgeable sales staff, and availability of educational materials, areas in which Invitrogen has made tremendous strides forward to appeal to their customers. While a bit surprising that Invitrogen would jump ahead of traditional RNA vendors in such a short period of time, these survey results signal that vendors need to pay close attention to the latest scientific trends and listen to the ever-changing needs of their customers in order to remain competitive in a difficult business environment.
The survey also revealed that the goals of RNAi research have changed slightly from survey results in 2004. Of note is the doubling of interest (from 3% in 2004 to 6% in 2005) in applying RNAi applications to therapeutics, marking an important but subtle shift in this rapidly developing field to applied research.
When asked to speculate on future trends for the RNAi market, vector-based siRNA was viewed as the most likely trend (27%), followed by microRNA (21%), modified siRNA (19%), and small hairpin RNA (13%). Such advances in RNA technology will raise expectations on investment returns for optimistic investors over the next several years.
The report, RNAi Report: A Revolutionary Technology, available from Biocompare, Inc., explores researchers future purchasing plans and the techniques, reagents, kits, and software they are currently using for studies of RNAi. More information about this and other reports available from Biocompare can be found at: https://www.biocompare.com/research
About Biocompare
Biocompare, Inc. (http://www.biocompare.com), headquartered in South San Francisco, California, is a global media company informing and connecting the buyers, users, and sellers of life science products. By combining an in-depth knowledge of life science products and new technologies with the power of the internet, Biocompare offers a dynamic, relevant, and innovative media-based marketplace for life science information.
SOURCE Biocompare, Inc.